Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Study of LAU-7b for the Treatment of Long COVID in Adults
- Conditions
- Long COVID
- Interventions
- Drug: LAU-7b for 3 cyclesDrug: LAU-7b for 1 cycle, then placeboOther: Placebo for 3 cycles
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Laurent Pharmaceuticals Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT05999435
- Locations
- 🇨🇦
CIUSS du Saguenay-Lac-St-Jean - Hôpital Chicoutimi, Chicoutimi, Quebec, Canada
🇨🇦Institut de Recherches Cliniques de Montréal, Montréal, Quebec, Canada
🇨🇦Montreal General Hospital, Montréal, Quebec, Canada
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Laurent Pharmaceuticals Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT04417257
- Locations
- 🇺🇸
Chandler Regional Medical Center / Mercy Gilbert Medical Center, Chandler, Arizona, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸University of California Davis Medical Center, Sacramento, California, United States
Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults
- First Posted Date
- 2017-08-29
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Laurent Pharmaceuticals Inc.
- Target Recruit Count
- 166
- Registration Number
- NCT03265288
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸UC Davis Medical Center, Division of Pulmonary & Critical Care Medicine, Sacramento, California, United States